Cargando…
Review: Evidence-based Clinical Research of Anti-obesity Supplements in Japan
BACKGROUND: The prevalence of obesity has increased dramatically throughout the world, and weight reduction through lifestyle management is urgently warranted. At present, numerous supplements advertised for their anti-overweight property are available in the Japanese market, but most of these lack...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Bentham Science Publishers
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4435568/ https://www.ncbi.nlm.nih.gov/pubmed/26005506 http://dx.doi.org/10.2174/1871522213666131118221347 |
_version_ | 1782371939315089408 |
---|---|
author | Yasueda, Asuka Ito, Toshinori Maeda, Kazuhisa |
author_facet | Yasueda, Asuka Ito, Toshinori Maeda, Kazuhisa |
author_sort | Yasueda, Asuka |
collection | PubMed |
description | BACKGROUND: The prevalence of obesity has increased dramatically throughout the world, and weight reduction through lifestyle management is urgently warranted. At present, numerous supplements advertised for their anti-overweight property are available in the Japanese market, but most of these lack proper evidence. Thus, we investigated dietary supplements that have been tested in clinical trials. SEARCH STRATEGY: We researched anti-obesity supplements in the Japanese market using the google search engine in Japanese with the key terms “anti-obesity supplements,” ”diet supplements,” and “weight reduction supplements.” RESULTS: We listed 49 companies that supply anti-obesity supplements. Of these, 11 had published clinical evidence of the anti-obesity efficacy of their supplements. These products contain the following active ingredients: Angelica keiskei, bofu-tsusho-san, capsaishin, DHA/EPA, forskohlii, garcinia cambogia, lactoferrin, L-carnitine, oligonol, tea catechin, and yeast hydrolysate. CONCLUSION: We obtained 11 supplements for which clinical evidence was published in medical journals in English. We also found 10 products for which clinical or animal evidence was published in Japanese. We expect that many companies will produce evidence of the efficacy of their products in the near future, thereby validating the use of dietary anti-obesity supplements in Japan. |
format | Online Article Text |
id | pubmed-4435568 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2013 |
publisher | Bentham Science Publishers |
record_format | MEDLINE/PubMed |
spelling | pubmed-44355682015-05-22 Review: Evidence-based Clinical Research of Anti-obesity Supplements in Japan Yasueda, Asuka Ito, Toshinori Maeda, Kazuhisa Immunol Endocr Metab Agents Med Chem Article BACKGROUND: The prevalence of obesity has increased dramatically throughout the world, and weight reduction through lifestyle management is urgently warranted. At present, numerous supplements advertised for their anti-overweight property are available in the Japanese market, but most of these lack proper evidence. Thus, we investigated dietary supplements that have been tested in clinical trials. SEARCH STRATEGY: We researched anti-obesity supplements in the Japanese market using the google search engine in Japanese with the key terms “anti-obesity supplements,” ”diet supplements,” and “weight reduction supplements.” RESULTS: We listed 49 companies that supply anti-obesity supplements. Of these, 11 had published clinical evidence of the anti-obesity efficacy of their supplements. These products contain the following active ingredients: Angelica keiskei, bofu-tsusho-san, capsaishin, DHA/EPA, forskohlii, garcinia cambogia, lactoferrin, L-carnitine, oligonol, tea catechin, and yeast hydrolysate. CONCLUSION: We obtained 11 supplements for which clinical evidence was published in medical journals in English. We also found 10 products for which clinical or animal evidence was published in Japanese. We expect that many companies will produce evidence of the efficacy of their products in the near future, thereby validating the use of dietary anti-obesity supplements in Japan. Bentham Science Publishers 2013-08 2013-08 /pmc/articles/PMC4435568/ /pubmed/26005506 http://dx.doi.org/10.2174/1871522213666131118221347 Text en © 2013 Bentham Science Publishers http://creativecommons.org/licenses/by-nc/3.0/ This is an open access article licensed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited. |
spellingShingle | Article Yasueda, Asuka Ito, Toshinori Maeda, Kazuhisa Review: Evidence-based Clinical Research of Anti-obesity Supplements in Japan |
title | Review: Evidence-based Clinical Research of Anti-obesity Supplements in Japan |
title_full | Review: Evidence-based Clinical Research of Anti-obesity Supplements in Japan |
title_fullStr | Review: Evidence-based Clinical Research of Anti-obesity Supplements in Japan |
title_full_unstemmed | Review: Evidence-based Clinical Research of Anti-obesity Supplements in Japan |
title_short | Review: Evidence-based Clinical Research of Anti-obesity Supplements in Japan |
title_sort | review: evidence-based clinical research of anti-obesity supplements in japan |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4435568/ https://www.ncbi.nlm.nih.gov/pubmed/26005506 http://dx.doi.org/10.2174/1871522213666131118221347 |
work_keys_str_mv | AT yasuedaasuka reviewevidencebasedclinicalresearchofantiobesitysupplementsinjapan AT itotoshinori reviewevidencebasedclinicalresearchofantiobesitysupplementsinjapan AT maedakazuhisa reviewevidencebasedclinicalresearchofantiobesitysupplementsinjapan |